Ledger.Open graph →
SEC Form D · Amendment · filed May 11, 2009

TALIGEN THERAPEUTICS INC

Offering
$65.0M
Sold
$26.0M
Exemption
—
Industry
Biotechnology
Location
CAMBRIDGE, MA
Type
—

People & firms on this filing (8)

Nicholas Galakatos · Cambridge, MADirectorTimothy C. Mills · Cambridge, MADirectorEd Hurwitz · Cambridge, MADirectorMichael M. Carroll · Richmond, VAExec · DirectorRobert R. Wotzcak · Gladstone, NJExec · DirectorWilliam B. Burton · Toronto, Ontario, CanadaDirectorGary E. German · Toronto, Ontario, CanadaDirectorMoustapha Niasse · Toronto, Ontario, CanadaDirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗